Skip to content

Research on Risk Screeningand Nutrition Support of Patients with Severe Right Heart Failure in Pulmonary Arterial Hypertension (PAH)

Research on Risk Screeningand Nutrition Support of Patients with Severe Right Heart Failure in Pulmonary Arterial Hypertension (PAH)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OON-17011417
Enrollment
Unknown
Registered
2017-05-16
Start date
2017-07-01
Completion date
Unknown
Last updated
2017-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary vascular disease

Interventions

Intervention group:nutritional support

Sponsors

The Affiliated Shanghai Pulmonary Hospital of Tongji University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. The patient shall sign the informed consent form. 2. Aged 18-85 years old; 3. Group 1 and 4 PH, including idiopathic pulmonary arterial hypertension, congenital heart disease after repair, CTEPH); 4. WHO PH class function III/IV.

Exclusion criteria

Exclusion criteria: 1. Patients with metabolic disease, including but not limited to hyperthyroidism, hypothyroidism, connective tissue disease, diabetes (which will still be included in preliminary baseline studies but will not be included in later stage of intervention studies), etc.; 2. Patients with Primary Hypohepatia or Renal Insufficiency; 3. Patients with Tumor.

Design outcomes

Primary

MeasureTime frame
skinfold thickness;Upper arm muscle circumference;height;weight;abdominal girth;biood routine examination;biood biochemistry;

Secondary

MeasureTime frame
Cardiac function indexes;Arterial blood gas;

Countries

China

Contacts

Public ContactLi Jinling

The Affiliated Shanghai Pulmonary Hospital of Tongji University

fanglishanghai@163.com+86 13918101478

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026